Articolul precedent |
Articolul urmator |
477 4 |
Ultima descărcare din IBN: 2023-12-02 12:38 |
SM ISO690:2012 TARAN, Natalia, HOTINEANU, Adrian, BURGOCI, Serghei, LUPAŞCO, Iulianna, PELTEC, Angela. Transplantul – o speranță la viață. Caz clinic. In: Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, 21-23 octombrie 2020, Chişinău. Chişinău: USMF, 2020, p. 454. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” 2020 | |||||||
Congresul "Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”" Chişinău, Moldova, 21-23 octombrie 2020 | |||||||
|
|||||||
Pag. 454-454 | |||||||
|
|||||||
Descarcă PDF | |||||||
Rezumat | |||||||
Background. Malnutrition increases mortality on the waiting list. Hydrothorax, renal dysfunction, MELD score >17 affect prognosis. Objective of the study. The case is 56 years old patient, cirrhosis, on the waiting list since 2017. Material and Methods. Investigated according to the LT protocol: biochemical analyzes, nasopharynx cultures, uroculture, hemoculture, pleural fluid, ascites; tumor markers, viral, autoimmune. Examined vital functions. Pulmonary CT: bilateral hydrothorax (D>S). Abdominal CT: ascites, splenomegaly, v. portae thrombosis, EDS- esophageal varices dgr II-III; HBV DNA 1 552 UI / ml, HDV RNA – 2 458 570 UI / ml. Results. Confirmed HBV /VHD HC, Child Pugh C (11 p). Hypersplenism dgr. II-III., MELD Na 20.7. Esophageal varices dgr II-III. Portal gastropathy. Recurrent hydrothorax. Thrombosis v. portae. Severe malnutrition BMI <18.5 portal enteropathy. Hyponatremia. LT from brain-dead donor, age <30 years, comorbidities abs. Rehabilitation period: Na+diminished, renal dysfunction, ascites, pseudomembranous colitis Cl. Difficile. Post-LT abdominal CT: stenosis v. portae, at anastomosis level, surgically resolved. Administered etiopathogenetic, immunosuppressive treatment adapted to disease features. 12 months post LT: absence of ascites, normal biochemical parameters, except creatinine 125 umoll, BMI –Conclusion. LT is the only treatment in the terminal stage. Postoperative evolution involves: age, nutritional status, renal dysfunction, viral infection, MELD score – receiver; age, quality of liver transplant – donor. |
|||||||
Cuvinte-cheie liver cirrhosis (LC), liver transplantation (LT), ciroza hepatica (CH), transplant hepatic (TH) |
|||||||
|